UBS Group
CTXR icon

UBS Group’s Citius Pharmaceuticals CTXR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$307K Buy
192,927
+125,712
+187% +$200K ﹤0.01% 5212
2025
Q1
$100K Buy
67,215
+39,648
+144% +$59.1K ﹤0.01% 5781
2024
Q4
$110K Buy
27,567
+26,962
+4,457% +$108K ﹤0.01% 5599
2024
Q3
$303 Sell
605
-62,174
-99% -$31.1K ﹤0.01% 7791
2024
Q2
$36.7K Sell
62,779
-71,834
-53% -$42K ﹤0.01% 5777
2024
Q1
$121K Sell
134,613
-2,900
-2% -$2.6K ﹤0.01% 4980
2023
Q4
$104K Buy
137,513
+39,489
+40% +$29.9K ﹤0.01% 4949
2023
Q3
$67K Buy
98,024
+26,896
+38% +$18.4K ﹤0.01% 4975
2023
Q2
$85.4K Buy
71,128
+70,762
+19,334% +$84.9K ﹤0.01% 5087
2023
Q1
$428 Buy
+366
New +$428 ﹤0.01% 7939
2022
Q3
Sell
-1,132
Closed -$1K 9273
2022
Q2
$1K Sell
1,132
-23,099
-95% -$20.4K ﹤0.01% 8797
2022
Q1
$43K Sell
24,231
-73,461
-75% -$130K ﹤0.01% 5612
2021
Q4
$150K Buy
97,692
+40,930
+72% +$62.8K ﹤0.01% 4879
2021
Q3
$115K Buy
56,762
+9,669
+21% +$19.6K ﹤0.01% 4674
2021
Q2
$164K Sell
47,093
-65,900
-58% -$229K ﹤0.01% 4480
2021
Q1
$201K Buy
112,993
+10,811
+11% +$19.2K ﹤0.01% 4510
2020
Q4
$104K Buy
+102,182
New +$104K ﹤0.01% 4677
2020
Q3
Sell
-7,774
Closed -$9K 7123
2020
Q2
$9K Buy
+7,774
New +$9K ﹤0.01% 6213
2019
Q3
Sell
-3,647
Closed -$4K 7018
2019
Q2
$4K Buy
+3,647
New +$4K ﹤0.01% 6564
2019
Q1
Sell
-665
Closed -$1K 6889
2018
Q4
$1K Buy
+665
New +$1K ﹤0.01% 6949
2018
Q3
Sell
-2,572
Closed -$6K 7041
2018
Q2
$6K Sell
2,572
-2,973
-54% -$6.94K ﹤0.01% 6471
2018
Q1
$17K Buy
5,545
+4,040
+268% +$12.4K ﹤0.01% 5626
2017
Q4
$6K Sell
1,505
-384
-20% -$1.53K ﹤0.01% 6313
2017
Q3
$6K Buy
+1,889
New +$6K ﹤0.01% 6216